Agilent Technologies Company Profile (NYSE:A)

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

Agilent Technologies declared a quarterly dividend on Wednesday, September 20th. Stockholders of record on Tuesday, October 3rd will be paid a dividend of $0.132 per share on Wednesday, October 25th. This represents a $0.53 annualized dividend and a dividend yield of 0.79%. The ex-dividend date of this dividend is Monday, October 2nd. View Agilent Technologies' Dividend History.

Agilent Technologies, Inc. (NYSE:A) issued its quarterly earnings data on Tuesday, August, 15th. The company reported $0.59 EPS for the quarter, beating analysts' consensus estimates of $0.52 by $0.07. The business earned $1.11 billion during the quarter, compared to analysts' expectations of $1.09 billion. Agilent Technologies had a return on equity of 16.95% and a net margin of 14.36%. The business's quarterly revenue was up 6.7% on a year-over-year basis. During the same period in the prior year, the company earned $0.49 earnings per share. View Agilent Technologies' Earnings History.

Agilent Technologies is scheduled to release their next quarterly earnings announcement on Monday, November, 20th 2017. View Earnings Estimates for Agilent Technologies.

Agilent Technologies updated its fourth quarter earnings guidance on Tuesday, August, 15th. The company provided earnings per share guidance of $0.60-0.62 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.60. The company issued revenue guidance of $1.15-1.17 billion, compared to the consensus revenue estimate of $1.15 billion.

13 equities research analysts have issued twelve-month price targets for Agilent Technologies' shares. Their predictions range from $53.00 to $70.00. On average, they anticipate Agilent Technologies' share price to reach $65.59 in the next year. View Analyst Ratings for Agilent Technologies.

Here are some recent quotes from research analysts about Agilent Technologies stock:

• 1. According to Zacks Investment Research, "Agilent Technologies is a broad-based OEM of test and measurement equipment. The company’s fiscal second quarter results were above the Zacks Consensus estimate. Year to date, the stock has outperformed the Industry it belongs to. The company’s decision to divest/wind up underperforming businesses has enhanced its focus on the new Agilent, while enabling expansion of a solid recurring revenue base and diversification of geographic and industrial operations for growth. Also, the company’s focus on aligning investments so as to be oriented toward more attractive growth avenues and innovative high-margin product launches are positives. Agilent’s broad-based portfolio and increased focus on segments offer higher growth potential. However, the macro weakness in the U.S. and Europe and forex headwinds remain concerns." (10/10/2017)
• 2. UBS AG analysts commented, "Agilent reported FY1Q17 results Tuesday with sales of $1.067b, above both ours and consensus estimates of $1.05b. Adj. EPS of $0.53 was also above both ours estimate of $0.50 and consensus estimates of $0.49. For FY17 management slightly lowered its revenue guidance to $4.33 - $4.35b from $4.35b - $4.37b, but increased the midpoint of its core growth guidance to 4.5% from 4.3%. Agilent maintained its FY17 adjusted EPS guidance to $2.10 - $2.16." (2/15/2017)

Agilent Technologies saw a drop in short interest in September. As of September 29th, there was short interest totalling 2,227,391 shares, a drop of 38.2% from the September 15th total of 3,601,536 shares. Based on an average daily trading volume, of 1,368,580 shares, the days-to-cover ratio is presently 1.6 days. Currently, 0.7% of the shares of the stock are short sold.

Some companies that are related to Agilent Technologies include Boston Scientific Corporation (BSX), Intuitive Surgical (ISRG), Koninklijke Philips N.V. (PHG), Illumina (ILMN), Cerner Corporation (CERN), Edwards Lifesciences Corporation (EW), Waters Corporation (WAT), ResMed (RMD), Hologic (HOLX), Varian Medical Systems (VAR), PerkinElmer (PKI), ABIOMED (ABMD), Bruker Corporation (BRKR), Alere (ALR), Quidel Corporation (QDEL), Mazor Robotics (MZOR), Natus Medical Incorporated (BABY) and Accelerate Diagnostics (AXDX).

Agilent Technologies' management team includes the folowing people:

• Michael R. McMullen, President, Chief Executive Officer, Director
• Didier Hirsch, Chief Financial Officer, Senior Vice President
• Michael Tang, Senior Vice President, General Counsel, Secretary
• Dominique P. Grau, Senior Vice President - Human Resources
• Henrik Ancher-Jensen, Senior Vice President, President - Order Fulfillment
• Mark Doak, Senior Vice President, President - Agilent CrossLab Group
• Patrick K. Kaltenbach, Senior Vice President, President - Life Sciences and Applied Markets Group
• Samraat Raha, Senior Vice President - Strategy and Corporate Development
• Jacob Thaysen, Senior Vice President, President - Diagnostics and Genomics Group
• Rodney Gonsalves, Chief Accounting Officer, Vice President, Corporate Controller

Agilent Technologies' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Fulton Bank N.A. (0.00%). Company insiders that own Agilent Technologies stock include Boon Hwee Koh, Didier Hirsch, Dominique Grau, Heidi Fields, James Cullen, Mark Doak, Michael R Mcmullen, Patrick Kaltenbach, Paul N Clark, Robert J Herbold and Rodney Gonsalves. View Institutional Ownership Trends for Agilent Technologies.

Agilent Technologies' stock was bought by a variety of institutional investors in the last quarter, including Fulton Bank N.A.. View Insider Buying and Selling for Agilent Technologies.

Shares of Agilent Technologies can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of Agilent Technologies stock can currently be purchased for approximately $66.88.